Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
CHEST Pulmonary|August 4, 2026
Mental Health Changes in Adolescents and Adults With Cystic Fibrosis After Initiation of Elexacaftor/Tezacaftor/Ivacaftor Therapy: Insights From the Longitudinal Resilience Impacted by Positive Stressful Events (RISE) StudyEls van der Heijden, Rutger M van den Bor, Marlou C Bierlaagh, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 11, 2016
Potentiator synergy in rectal organoids carrying S1251N, G551D, or F508del CFTR mutationsJohanna F Dekkers, Peter Van Mourik, Annelotte M Vonk, et al.Nature Medicine|June 4, 2013
A functional CFTR assay using primary cystic fibrosis intestinal organoidsJohanna F Dekkers, Caroline L Wiegerinck, Hugo R de Jonge, et al.The Lancet. Respiratory Medicine|May 20, 2014
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trialEitan Kerem, Michael W Konstan, Kris De Boeck, et al.Science Translational Medicine|June 24, 2016
Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosisJohanna F Dekkers, Gitte Berkers, Evelien Kruisselbrink, et al.The European Respiratory Journal|July 30, 2016
β2-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosisLodewijk A W Vijftigschild, Gitte Berkers, Johanna F Dekkers, et al.Thorax|August 10, 2011
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutationJ P Clancy, Steven M Rowe, Frank J Accurso, et al.Pageof 3